Comparison of trimethoprim-sulfamethoxazole, cephadroxil and cefprozil as prophylaxis for recurrent urinary tract infections in children

Journal of Chemotherapy

Volumn 16, Issue 1, 2004, Pages 77-81

  Belet, N ^a   Islek ^a   Belet, U ^a   Sunter, A T ^a   Kucukoduk S ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Cefprozil; Cephadroxil; Children; Pediatric UTI; Prophylaxis; Recurrent urinary tract infection; Trimethoprim sulfamethoxazole; UTI

Indexed keywords

CEFADROXIL; CEFPROZIL; COTRIMOXAZOLE;

ARTICLE; BACTERIURIA; CHEMOPROPHYLAXIS; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SYMPTOMATOLOGY; URINARY TRACT INFECTION;

EID: 1942454735     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.1.77     Document Type: Article

References (23)

1. Saux NL, Pham B, Moher D. Evaluating the benefits of antimicrobial prophylaxis to prevent urinary tract infections in children: a systematic review. CMAJ 2000; 163 (5): 523-529.
2. Zelikovic I, Adelman RD, Nancarrow PA. Urinary tract infections in children and update. West J Med 1992; 157 (5): 554-561.
3. Committee on Infectious Diseases American Academy of Pediatrics. Antimicrobial prophylaxis. In: Peter G, ed. Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village (IL). 1997: 1469-1473.
4. Ahmed SM, Swedlund SK. Evaluation and treatment of urinary tract infections. Am Fam Physician 1998; 57 (7): 1573-1580.
5. Chon CH, Lai FC, Shortliffe LMD. Pediatric urinary tract infections. Ped Clin North Am 2001; 48 (6): 1441-1459.
6. Hoberman A, Wald ER. Treatment of urinary tract infections. Pediatr Infect Dis J 1999; 18 (11): 1020-1021.
7. Bollgren I. Antibacterial prophylaxis in children with urinary tract infection. Acta Paediatr Suppl 1999; 88 (431): 48-52.
8. Seracini D, Materassi M, Danti A. Non-comparative open study of the efficacy and tolerance of cefaclor in the prevention of urinary tract infections in children. Pediatr Med Chir 1996; 18 (4): 383-385.
9. Stranieri G, Zampogna S, Telapi V, et al. cefixime for the prophylaxis of urinary tract infections in children with malformative uropathies: an open study. Eur Rev Med Pharmacol Sci 2003; 7 (2): 57-64.
10. Lettgen B, Troster K. prophylaxis of recurrent urinary tract infections in children. Results of an open, controlled and randomized study about the efficacy and tolerance of cefixime compared to nitrofurantoin. Klin Padiatr 2002; 214 (6): 353-358.
11. Pomeranz A, El-Khayan A, Korzets Z, et al. a bioassay evaluation of the urinary antibacterial efficacy of low dose prophylactic antibiotics in children with vesicoureteral reflux. J Urol 2000; 164 (3 Pt 2): 1070-1073.
12. Shapiro E, Elder JS. The office management of recurrent urinary tract infection and vesicoureteral reflux in children. Urol Clin North Am 1998; 25 (4): 725-734.
13. Lettgen B. Prevention of recurrent urinary tract infections in female children. Curr Ther Res 1996; 57 (6): 464-475.
14. Lohr JA, Nunley DH, Howards SS, Ford RF. Prevention of recurrent urinary tract infections in girls. Pediatrics 1977; 59 (4): 562-565.
15. Smellie JM, Katz G, Grüneberg RN. Controlled trial of prophylactic treatment in childhood urinary-tract infection. Lancet 1978; 22 (8082): 175-178.
16. Brendstrup L, Hjelt K, Petersen KE, et al. Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. Acta Paediatr Scand 1990; 79 (12): 1225-1234.
17. Williams G, Lee A, Craig J. Antibiotics for the prevention of urinary tract infection in children: a systematic review of randomized controlled trials. J Pediatr 2001; 138 (6): 868-874.
18. Stamm WE. An epidemic of urinary tract infections? N Eng J Med 2001; 345 (6): 1055-1057.
19. Manges AR, Johnson JR, Foxman B, O'Bryan TT, Fullerton KE, Riley LW. Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Eng J Med 2001; 345 (4): 1007-1013.
20. Allen UD, Macdonald N, Fuite L, Chan F, Stephens D. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children. CMAJ 1999; 160 (10): 1436-1440.
21. Ginsburg CM, McCracken GH. Cefaclor and cefadroxil: a commentary on their properties and possible indications for use in pediatrics. J Pediatr 1980; 96 (2): 340-342.
22. Puhakka H, Virolainen E. Cefadroxil in the treatment of susceptible infections in infants and children. Drugs 1986; 32 (3): 21-28.
23. Stutman HR. Cefprozil. Pediatr Ann 1993; 22 (3): 167-176.